EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis



A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis



Carcinogenesis 29(10): 1963-1966



A G to C polymorphism (rs2910164) is located within the sequence of miR-146a precursor, which leads to a change from a G:U pair to a C:U mismatch in its stem region. The predicted miR-146a target genes include BRCA1 and BRCA2, which are key breast and ovarian cancer genes. To examine whether rs2910164 plays any role in breast and/or ovarian cancer, we studied associations between this polymorphism and age of diagnosis in 42 patients with familial breast cancer and 82 patients with familial ovarian cancer. Breast cancer patients who had at least one miR-146a variant allele were diagnosed at an earlier age than with no variant alleles (median age 45 versus 56, P = 0.029) and ovarian cancer patients who had at least one miR-146a variant allele were diagnosed younger than women without any variant allele (median age 45 versus 50, P = 0.014). In further functional analysis, we found that the variant allele displayed increased production of mature miR-146a from the precursor microRNA compared with the common allele. Consistent with the target prediction, in a target in vitro assay, we observed that miR-146a could bind to the 3' untranslated regions (UTRs) of BRCA1 and BRCA2 messenger RNAs (mRNAs) and potentially modulate their mRNA expression. Intriguingly, the binding capacity between the 3' UTR of BRCA1 and miR-146a was statistically significantly stronger in variant C allele than those in common G allele (P = 0.046). Taken together, our data suggest that breast/ovarian cancer patients with variant C allele miR-146a may have high levels of mature miR-146 and that these variants predispose them to an earlier age of onset of familial breast and ovarian cancers.

(PDF emailed within 0-6 h: $19.90)

Accession: 051137593

Download citation: RISBibTeXText

PMID: 18660546

DOI: 10.1093/carcin/bgn172



Related references

A functional polymorphism in Pre-miR-146a gene is associated with prostate cancer risk and mature miR-146a expression in vivo. Prostate 70(5): 467-472, 2010

Association between hsa-mir-146a genotype and tumor age-of-onset in BRCA1/BRCA2-negative familial breast and ovarian cancer patients. Carcinogenesis 31(12): 2124-2126, 2011

The presence of hereditary BRCA1 gene mutations in women with familial breast cancer or familial ovarian cancer and the frequency of the occurrence of these tumours in their relatives. EJC Supplements 2(3): 152, March, 2004

Lack of association between androgen receptor CAG polymorphism and familial breast/ovarian cancer. Cancer Letters 168(1): 31-36, July 10, 2001

Association of the BRCA1 promoter polymorphism rs11655505 with the risk of familial breast and/or ovarian cancer. Familial Cancer 12(4): 691-698, 2014

A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma. Carcinogenesis 29(11): 2126-2131, 2008

Gene for familial breast and ovarian cancer. Lancet 341(8852): 1060-1061, 1993

A functional polymorphism in the pre-miR-146a gene is associated with risk and prognosis in adult glioma. Journal of Neuro-Oncology 105(3): 639-646, 2012

The search for the familial breast/ovarian cancer gene. Trends in Genetics 9(1): 22-26, 1993

Psychosocial aspects of predictive gene diagnosis in familial breast and ovarian carcinomas. Deutsche Medizinische Wochenschrift 124(12): 361-362, 1999

The CYP3A4*1B polymorphism has no functional significance and is not associated with risk of breast or ovarian cancer. Pharmacogenetics 12(5): 355-366, 2002

Guidelines for evaluation of patients at risk for inherited breast and ovarian cancer: recommendations of the Department of Defense Familial Breast/Ovarian Cancer Research Project. Military Medicine 167(2): 93-98, 2002

A functional polymorphism in Pre-miR-146a is associated with susceptibility to gastric cancer in a Chinese population. Dna and Cell Biology 31(7): 1290-1295, 2012

Two novel variants in the 3'UTR of the BRCA1 gene in familial breast and/or ovarian cancer. Breast Cancer Research and Treatment 125(3): 885-891, 2011